Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)-Reference-Cited by-同舟云学术

Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)

Published:2023-07-08 Issue:8 Volume:37 Page:1753-1756
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Gurney Mark^ORCID,Mangaonkar Abhishek A.^ORCID,Lasho Terra,Finke Christy,Al-Kali Aref^ORCID,Gangat Naseema,Shah Mithun V.^ORCID,Alkhateeb Hassan B.,Tefferi Ayalew^ORCID,Sallman David^ORCID,Xie Zhuoer^ORCID,Viswanatha David,Reichard Kaaren,Al Ali Najla,Komrokji Rami^ORCID,Padron Eric^ORCID,Patnaik Mrinal M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-01964-3.pdf

Reference15 articles.

1. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.

2. Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.

3. Cumbo C, Tota G, Anelli L, Zagaria A, Specchia G, Albano F. TP53 in myelodysplastic syndromes: recent biological and clinical findings. Int J Mol Sci. 2020;21. https://doi.org/10.3390/IJMS21103432.

4. Stengel A, Kern W, Haferlach T, Meggendorfer M, Fasan A, Haferlach C. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases. Leukemia. 2017;31:705–11.

5. Mei M, Pillai R, Kim S, Estrada-Merly N, Afkhami M, Yang L, et al. The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis. Haematologica. 2023;108:150–60.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Molecular Pathogenesis and Diagnosis of Chronic Myelomonocytic Leukemia;Advances in Molecular Pathology;2024-08

2. Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia;Leukemia & Lymphoma;2024-07-14

3. Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia;Blood Cancer Journal;2024-07-12

4. TP53 Y220C mutations in patients with myeloid malignancies;Leukemia & Lymphoma;2024-06-10